The lubricant coating is also gone
Post-marketing surveillance and adherence to high-quality production standards must continue after the drug is approved
This deceleration is physiologically normal and reflects metabolic adaptation rather than treatment failure
Studies on GLP-1based medications, including tirzepatide, consistently show that weight can start to return within a few months after stoppingespecially without a plan
However, in patients with established atherosclerotic cardiovascular disease, high cardiovascular risk, or chronic kidney disease, they are now recommended as first-line therapy [22]
We walk through all of this during a consultation, based on your numbers and your goals, without pushing toward any particular path